Comparing Aimei Health Technology (AFJK) and Its Competitors

Aimei Health Technology (NASDAQ:AFJK) is one of 89 public companies in the “UNCLASSIFIED” industry, but how does it contrast to its rivals? We will compare Aimei Health Technology to related companies based on the strength of its analyst recommendations, valuation, risk, profitability, earnings, dividends and institutional ownership.

Valuation and Earnings

This table compares Aimei Health Technology and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	50.87
Aimei Health Technology Competitors	$42.00 million	-$18.54 million	94.34

Aimei Health Technology’s rivals have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Aimei Health Technology and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Institutional and Insider Ownership

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Comparatively, 42.9% of shares of all “UNCLASSIFIED” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings for Aimei Health Technology and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	0	1	0	0	2.00
Aimei Health Technology Competitors	231	266	217	3	1.99

As a group, “UNCLASSIFIED” companies have a potential upside of 101.09%. Given Aimei Health Technology’s rivals higher possible upside, analysts plainly believe Aimei Health Technology has less favorable growth aspects than its rivals.

Volatility and Risk

Aimei Health Technology has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s rivals have a beta of -0.08, indicating that their average stock price is 108% less volatile than the S&P 500.

Summary

Aimei Health Technology rivals beat Aimei Health Technology on 9 of the 13 factors compared.

Aimei Health Technology Company Profile

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.